BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34096050)

  • 1. The time for new biomarkers in mycosis fungoides/Sézary syndrome is here.
    Ortiz-Romero PL
    Br J Dermatol; 2021 Aug; 185(2):250-251. PubMed ID: 34096050
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mycosis fungoides and Sézary syndrome, so-called cutaneous T-cell lymphoma].
    Rupniewska ZM
    Postepy Hig Med Dosw; 1982; 36(4):231-49. PubMed ID: 6764803
    [No Abstract]   [Full Text] [Related]  

  • 3. Cutaneous T-cell lymphoma (mycosis fungoides).
    Lorincz AL
    Lancet; 1996 Mar; 347(9005):871-6. PubMed ID: 8622396
    [No Abstract]   [Full Text] [Related]  

  • 4. Survival and Prognostic Factors in Patients with Aggressive Cutaneous T-cell Lymphomas.
    Franceschi J; Ehret M; Visseaux L; Durlach A; Barbe C; Durot É; Grange F
    Acta Derm Venereol; 2022 Mar; 102():adv00676. PubMed ID: 35083494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
    Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
    J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycosis fungoides and Sézary syndrome: Australian clinical practice statement.
    Bhabha FK; McCormack C; Wells J; Campbell BA; Newland K; Lade S; Buelens O; Joske D; Shortt J; Mapp S; Radeski D; Hertzberg M; Khot A; Van Der Weyden C; Khoo C; Hawkes E; Prince HM
    Australas J Dermatol; 2021 Feb; 62(1):e8-e18. PubMed ID: 33368169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical characteristics of mycosis fungoides and Sézary syndrome].
    Krc L; Dobesová J; Bucek M; Dusek J; Macák J; Galuszková D; Jurysek O
    Vnitr Lek; 1997 May; 43(5):285-9. PubMed ID: 9601850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycosis fungoides and Sézary syndrome - Review and outlook.
    Latzka J; Trautinger F
    J Dtsch Dermatol Ges; 2023 Apr; 21(4):386-391. PubMed ID: 36971307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous T-cell lymphoma. Refinement in the application of controversial histologic criteria.
    Glusac EJ; Shapiro PE; McNiff JM
    Dermatol Clin; 1999 Jul; 17(3):601-14, ix. PubMed ID: 10410861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The biomarker landscape in mycosis fungoides and Sézary syndrome.
    Dulmage B; Geskin L; Guitart J; Akilov OE
    Exp Dermatol; 2017 Aug; 26(8):668-676. PubMed ID: 27897325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current therapeutic options in Mycosis fungoides and Sézary syndrome].
    Albrecht JD; Nicolay JP
    Hautarzt; 2022 Jan; 73(1):75-85. PubMed ID: 34988613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Item no 164: malignant lymphoma: cutaneous lymphoma].
    CEDEF
    Ann Dermatol Venereol; 2008 Nov; 135(11 Suppl):F160-2. PubMed ID: 18984207
    [No Abstract]   [Full Text] [Related]  

  • 13. [Not Available].
    Cedef
    Ann Dermatol Venereol; 2018 Mar; 145 Suppl 1():S186-S188. PubMed ID: 29475620
    [No Abstract]   [Full Text] [Related]  

  • 14. [T cell subsets and nuclear contour index of skin-infiltrating T cells in mycosis fungoides and Sézary syndrome].
    Iwahara K
    Nihon Hifuka Gakkai Zasshi; 1984 Nov; 94(13):1499-507. PubMed ID: 6335535
    [No Abstract]   [Full Text] [Related]  

  • 15. Cutaneous Lymphomas - Part I: Mycosis Fungoides, Sézary Syndrome, and CD30
    Pujol RM; Gallardo F
    Actas Dermosifiliogr (Engl Ed); 2021 Jan; 112(1):14-23. PubMed ID: 32896500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New options in diagnosis and management of mycosis fungoides and Sézary syndrome.
    Enke CA
    Oncology (Williston Park); 2010 May; 24(6):507-8. PubMed ID: 20568591
    [No Abstract]   [Full Text] [Related]  

  • 17. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary Cutaneous T-Cell Lymphomas: Mycosis Fungoides and Sezary Syndrome.
    Querfeld C; Zain J; Rosen ST
    Cancer Treat Res; 2019; 176():225-248. PubMed ID: 30596221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous T cell lymphoma: mycosis fungoides, Sézary syndrome, and other variants.
    Edelson RL
    J Am Acad Dermatol; 1980 Feb; 2(2):89-106. PubMed ID: 6988470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent developments in the early diagnosis of mycosis fungoides and Sézary's syndrome.
    Willemze R
    Eur J Cancer Clin Oncol; 1987 Nov; 23(11):1581-3. PubMed ID: 3428330
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.